(marcus evans: London) -- Pharmaceutical quality systems have shifted in recent years from a traditional model to a more global, dynamic, and risk-based approach, enhanced especially by regulatory authorities and economic environment. marcus evans is organizing the conference, “Quality Risk Management & Process Validation in the Product Life Cycle,” which will be held Sept. 28–30, 2016, in Berlin.
ADVERTISEMENT |
This conference will help attendees to implement a quality risk management approach into their existing quality systems. It will also provide a better understanding of how to assess and evaluate risks in their companies and with third-party partners.
By attending this conference, attendees will be able to be part of more than 14 hours of focused, end-user-driven case studies, interactive panel discussions, and workshops. In addition, delegates will have the opportunity to network with senior-level executives and learn about the latest developments and trends in pharmaceutical quality systems.
The key topic areas are:
• Effectively integrate ICH Q8, Q9, Q10, and Q11 guidelines into the quality system
• Discuss regulatory expectation on process validation
• Define an efficient quality risk management system and tools across the global quality system
• Design efficient processes to ensure quality control
• Correctly handle third-party partners within quality risk management processes
• Apply efficient continuous process verification to monitor the system
Read the interview with conference guest speaker Michael Schousboe, principal specialist, quality risk management at Novo Nordisk.
For more information about this event, contact Yiota Andreou at yiotaa@marcusevanscy.com and visit the event website here.
Add new comment